LOCUS       TF7L2_HUMAN              619 aa            linear   PRI 14-DEC-2022
DEFINITION  RecName: Full=Transcription factor 7-like 2; AltName: Full=HMG box
            transcription factor 4; AltName: Full=T-cell-specific transcription
            factor 4; Short=T-cell factor 4; Short=TCF-4; Short=hTCF-4.
ACCESSION   Q9NQB0
VERSION     Q9NQB0.2
KEYWORDS    3D-structure; Activator; Alternative splicing; Diabetes mellitus;
            DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein; Reference
            proteome; Repressor; Transcription; Transcription regulation; Ubl
            conjugation; Wnt signaling pathway.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
DBSOURCE    UniProtKB: locus TF7L2_HUMAN, accession Q9NQB0; class: standard. extra accessions:B4DRJ8,B9X074,C6ZRJ8,C6ZRK0,E2GH14,E2GH19,E2GH20,E2GH24, E2GH25,E9PFH9,F8W742,F8W7T5,O00185,Q9NQB1,Q9NQB2,Q9NQB3,Q9NQB4, Q9NQB5,Q9NQB6,Q9NQB7,Q9ULC2 created: Mar 25, 2003. sequence updated: Mar 25, 2003. annotation updated: Dec 14, 2022. xrefs: Y11306.2, CAA72166.2, AJ270770.1, CAB97212.1, AJ270771.1, AJ270772.1, AJ270773.1, AJ270774.1, AJ270775.1, AJ270776.1, AJ270778.1, CAB97213.1, CAB97214.1, AJ270777.1, CAB97215.1, CAB97216.1, CAB97217.1, CAB97218.1, CAB97219.1, FJ010167.1, ACI28525.1, FJ010169.1, ACI28527.1, FJ010172.1, ACI28530.1, HM352839.1, ADK35175.1, HM352842.1, ADK35178.1, HM352844.1, ADK35180.1, HM352845.1, ADK35187.1, HM352846.1, ADK35181.1, HM352847.1, ADK35182.1, HM352849.1, ADK35184.1, HM352850.1, ADK35185.1, AB440195.1, BAH24004.1, AK299295.1, BAG61310.1, AL135792.10, AL158212.15, AL445486.10, AL451084.19, CH471066.2, EAW49513.1, EAW49515.1, EAW49516.1, BC032656.1, AAH32656.1, AB034691.1, BAA86225.1, S22807, NP_001139746.1, NP_001139755.1, NP_001139756.1, NP_001139758.1, NP_001185455.1, NP_001185457.1, NP_001185460.1, XP_005270141.1, XP_005270146.1, XP_005270153.1, XP_005270160.1, XP_016872081.1, XP_016872082.1, 1JDH_B, 1JPW_D, 1JPW_E, 1JPW_F, 2GL7_B, 2GL7_E xrefs (non-sequence databases): CCDS:CCDS53577.1, CCDS:CCDS53578.1, CCDS:CCDS55729.1, CCDS:CCDS7576.1, CCDS:CCDS86148.1, PDBsum:1JDH, PDBsum:1JPW, PDBsum:2GL7, AlphaFoldDB:Q9NQB0, SMR:Q9NQB0, BioGRID:112795, CORUM:Q9NQB0, DIP:DIP-36236N, IntAct:Q9NQB0, MINT:Q9NQB0, STRING:9606.ENSP00000358404, BindingDB:Q9NQB0, ChEMBL:CHEMBL3038511, iPTMnet:Q9NQB0, PhosphoSitePlus:Q9NQB0, BioMuta:TCF7L2, DMDM:29337146, EPD:Q9NQB0, jPOST:Q9NQB0, MassIVE:Q9NQB0, MaxQB:Q9NQB0, PaxDb:Q9NQB0, PeptideAtlas:Q9NQB0, ProteomicsDB:15216, ProteomicsDB:29884, ProteomicsDB:30005, ProteomicsDB:82120, ProteomicsDB:82121, ProteomicsDB:82122, ProteomicsDB:82123, ProteomicsDB:82124, ProteomicsDB:82125, ProteomicsDB:82126, ProteomicsDB:82127, ProteomicsDB:82128, ProteomicsDB:82129, Antibodypedia:31824, DNASU:6934, Ensembl:ENST00000352065.10, Ensembl:ENSP00000344823.5, Ensembl:ENSG00000148737.17, Ensembl:ENST00000355717.9, Ensembl:ENSP00000347949.4, Ensembl:ENST00000355995.9, Ensembl:ENSP00000348274.4, Ensembl:ENST00000369397.8, Ensembl:ENSP00000358404.4, Ensembl:ENST00000538897.5, Ensembl:ENSP00000446172.1, Ensembl:ENST00000627217.3, Ensembl:ENSP00000486891.1, GeneID:6934, KEGG:hsa:6934, MANE-Select:ENST00000355995.9, UCSC:uc001lac.5, AGR:HGNC:11641, CTD:6934, DisGeNET:6934, GeneCards:TCF7L2, HGNC:11641, HPA:ENSG00000148737, MalaCards:TCF7L2, MIM:125853, MIM:602228, neXtProt:NX_Q9NQB0, OpenTargets:ENSG00000148737, Orphanet:528084, PharmGKB:PA36394, VEuPathDB:HostDB:ENSG00000148737, eggNOG:KOG3248, GeneTree:ENSGT00940000155535, HOGENOM:CLU_013229_5_0_1, InParanoid:Q9NQB0, OMA:WCVESNK, OrthoDB:807716at2759, PhylomeDB:Q9NQB0, TreeFam:TF318448, PathwayCommons:Q9NQB0, Reactome:R-HSA-201722, Reactome:R-HSA-3769402, Reactome:R-HSA-381771, Reactome:R-HSA-4086398, Reactome:R-HSA-4411364, Reactome:R-HSA-4641265, Reactome:R-HSA-5339700, Reactome:R-HSA-8853884, Reactome:R-HSA-8951430, SignaLink:Q9NQB0, SIGNOR:Q9NQB0, BioGRID-ORCS:6934, ChiTaRS:TCF7L2, EvolutionaryTrace:Q9NQB0, GeneWiki:TCF7L2, GenomeRNAi:6934, Pharos:Q9NQB0, PRO:PR:Q9NQB0, Proteomes:UP000005640, RNAct:Q9NQB0, Bgee:ENSG00000148737, ExpressionAtlas:Q9NQB0, Genevisible:Q9NQB0, GO:1990907, GO:0070369, GO:0071664, GO:0000785, GO:0005654, GO:0005634, GO:0016605, GO:0032993, GO:0070016, GO:0008013, GO:0003700, GO:0000981, GO:0045295, GO:0060090, GO:0016922, GO:0003676, GO:0019901, GO:0000978, GO:0061629, GO:0043565, GO:0000976, GO:0001568, GO:0060070, GO:0044334, GO:0045444, GO:0042593, GO:0043570, GO:0048625, GO:0090090, GO:0043433, GO:0045892, GO:2001237, GO:0000122, GO:2000675, GO:0031016, GO:0050679, GO:0010909, GO:0032024, GO:0032092, GO:0051897, GO:1900182, GO:0045944, GO:0032350, GO:0048660, GO:0006357, GO:0009749, DisProt:DP00175, Gene3D:1.10.30.10, Gene3D:4.10.900.10, IDEAL:IID00100, InterPro:IPR027397, InterPro:IPR013558, InterPro:IPR009071, InterPro:IPR036910, InterPro:IPR024940, PANTHER:PTHR10373, Pfam:PF08347, Pfam:PF00505, SMART:SM00398, SUPFAM:SSF47095, PROSITE:PS50118
REFERENCE   1  (residues 1 to 619)
  AUTHORS   Korinek,V., Barker,N., Morin,P.J., van Wichen,D., de Weger,R.,
            Kinzler,K.W., Vogelstein,B. and Clevers,H.
  TITLE     Constitutive transcriptional activation by a beta-catenin-Tcf
            complex in APC-/- colon carcinoma
  JOURNAL   Science 275 (5307), 1784-1787 (1997)
   PUBMED   9065401
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 8 AND 9), AND INTERACTION WITH
            CTNNB1.; TISSUE=Fetus
REFERENCE   2  (residues 1 to 619)
  AUTHORS   Duval,A., Rolland,S., Tubacher,E., Bui,H., Thomas,G. and Hamelin,R.
  TITLE     The human T-cell transcription factor-4 gene: structure, extensive
            characterization of alternative splicings, and mutational analysis
            in colorectal cancer cell lines
  JOURNAL   Cancer Res 60 (14), 3872-3879 (2000)
   PUBMED   10919662
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 2; 3; 4; 5; 6; 7 AND
            9), AND VARIANT ASN-346.
REFERENCE   3  (residues 1 to 619)
  AUTHORS   Prokunina-Olsson,L., Welch,C., Hansson,O., Adhikari,N., Scott,L.J.,
            Usher,N., Tong,M., Sprau,A., Swift,A., Bonnycastle,L.L., Erdos,M.R.,
            He,Z., Saxena,R., Harmon,B., Kotova,O., Hoffman,E.P., Altshuler,D.,
            Groop,L., Boehnke,M., Collins,F.S. and Hall,J.L.
  TITLE     Tissue-specific alternative splicing of TCF7L2
  JOURNAL   Hum Mol Genet 18 (20), 3795-3804 (2009)
   PUBMED   19602480
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 12; 13 AND 14), AND ALTERNATIVE
            SPLICING.; TISSUE=Brain
REFERENCE   4  (residues 1 to 619)
  AUTHORS   Tsedensodnom,O., Koga,H., Rosenberg,S.A., Nambotin,S.B.,
            Carroll,J.J., Wands,J.R. and Kim,M.
  TITLE     Identification of T-cell factor-4 isoforms that contribute to the
            malignant phenotype of hepatocellular carcinoma cells
  JOURNAL   Exp Cell Res 317 (7), 920-931 (2011)
   PUBMED   21256126
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 6; 9; 13; 14; 15 AND 17),
            AND ALTERNATIVE SPLICING.
REFERENCE   5  (residues 1 to 619)
  AUTHORS   Iseki,H., Takeda,A., Andou,T., Takahashi,N., Ban,S., Kurochkin,I.V.,
            Okazaki,Y. and Koyama,I.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-JUN-2008) to the EMBL/GenBank/DDBJ databases
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 9).; TISSUE=Colon
REFERENCE   6  (residues 1 to 619)
  AUTHORS   Ota,T., Suzuki,Y., Nishikawa,T., Otsuki,T., Sugiyama,T., Irie,R.,
            Wakamatsu,A., Hayashi,K., Sato,H., Nagai,K., Kimura,K., Makita,H.,
            Sekine,M., Obayashi,M., Nishi,T., Shibahara,T., Tanaka,T., Ishii,S.,
            Yamamoto,J., Saito,K., Kawai,Y., Isono,Y., Nakamura,Y., Nagahari,K.,
            Murakami,K., Yasuda,T., Iwayanagi,T., Wagatsuma,M., Shiratori,A.,
            Sudo,H., Hosoiri,T., Kaku,Y., Kodaira,H., Kondo,H., Sugawara,M.,
            Takahashi,M., Kanda,K., Yokoi,T., Furuya,T., Kikkawa,E., Omura,Y.,
            Abe,K., Kamihara,K., Katsuta,N., Sato,K., Tanikawa,M., Yamazaki,M.,
            Ninomiya,K., Ishibashi,T., Yamashita,H., Murakawa,K., Fujimori,K.,
            Tanai,H., Kimata,M., Watanabe,M., Hiraoka,S., Chiba,Y., Ishida,S.,
            Ono,Y., Takiguchi,S., Watanabe,S., Yosida,M., Hotuta,T., Kusano,J.,
            Kanehori,K., Takahashi-Fujii,A., Hara,H., Tanase,T.O., Nomura,Y.,
            Togiya,S., Komai,F., Hara,R., Takeuchi,K., Arita,M., Imose,N.,
            Musashino,K., Yuuki,H., Oshima,A., Sasaki,N., Aotsuka,S.,
            Yoshikawa,Y., Matsunawa,H., Ichihara,T., Shiohata,N., Sano,S.,
            Moriya,S., Momiyama,H., Satoh,N., Takami,S., Terashima,Y.,
            Suzuki,O., Nakagawa,S., Senoh,A., Mizoguchi,H., Goto,Y., Shimizu,F.,
            Wakebe,H., Hishigaki,H., Watanabe,T., Sugiyama,A., Takemoto,M.,
            Kawakami,B., Yamazaki,M., Watanabe,K., Kumagai,A., Itakura,S.,
            Fukuzumi,Y., Fujimori,Y., Komiyama,M., Tashiro,H., Tanigami,A.,
            Fujiwara,T., Ono,T., Yamada,K., Fujii,Y., Ozaki,K., Hirao,M.,
            Ohmori,Y., Kawabata,A., Hikiji,T., Kobatake,N., Inagaki,H.,
            Ikema,Y., Okamoto,S., Okitani,R., Kawakami,T., Noguchi,S., Itoh,T.,
            Shigeta,K., Senba,T., Matsumura,K., Nakajima,Y., Mizuno,T.,
            Morinaga,M., Sasaki,M., Togashi,T., Oyama,M., Hata,H., Watanabe,M.,
            Komatsu,T., Mizushima-Sugano,J., Satoh,T., Shirai,Y., Takahashi,Y.,
            Nakagawa,K., Okumura,K., Nagase,T., Nomura,N., Kikuchi,H.,
            Masuho,Y., Yamashita,R., Nakai,K., Yada,T., Nakamura,Y., Ohara,O.,
            Isogai,T. and Sugano,S.
  TITLE     Complete sequencing and characterization of 21,243 full-length human
            cDNAs
  JOURNAL   Nat Genet 36 (1), 40-45 (2004)
   PUBMED   14702039
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 14).
REFERENCE   7  (residues 1 to 619)
  AUTHORS   Deloukas,P., Earthrowl,M.E., Grafham,D.V., Rubenfield,M., French,L.,
            Steward,C.A., Sims,S.K., Jones,M.C., Searle,S., Scott,C., Howe,K.,
            Hunt,S.E., Andrews,T.D., Gilbert,J.G., Swarbreck,D., Ashurst,J.L.,
            Taylor,A., Battles,J., Bird,C.P., Ainscough,R., Almeida,J.P.,
            Ashwell,R.I., Ambrose,K.D., Babbage,A.K., Bagguley,C.L., Bailey,J.,
            Banerjee,R., Bates,K., Beasley,H., Bray-Allen,S., Brown,A.J.,
            Brown,J.Y., Burford,D.C., Burrill,W., Burton,J., Cahill,P.,
            Camire,D., Carter,N.P., Chapman,J.C., Clark,S.Y., Clarke,G.,
            Clee,C.M., Clegg,S., Corby,N., Coulson,A., Dhami,P., Dutta,I.,
            Dunn,M., Faulkner,L., Frankish,A., Frankland,J.A., Garner,P.,
            Garnett,J., Gribble,S., Griffiths,C., Grocock,R., Gustafson,E.,
            Hammond,S., Harley,J.L., Hart,E., Heath,P.D., Ho,T.P., Hopkins,B.,
            Horne,J., Howden,P.J., Huckle,E., Hynds,C., Johnson,C., Johnson,D.,
            Kana,A., Kay,M., Kimberley,A.M., Kershaw,J.K., Kokkinaki,M.,
            Laird,G.K., Lawlor,S., Lee,H.M., Leongamornlert,D.A., Laird,G.,
            Lloyd,C., Lloyd,D.M., Loveland,J., Lovell,J., McLaren,S.,
            McLay,K.E., McMurray,A., Mashreghi-Mohammadi,M., Matthews,L.,
            Milne,S., Nickerson,T., Nguyen,M., Overton-Larty,E., Palmer,S.A.,
            Pearce,A.V., Peck,A.I., Pelan,S., Phillimore,B., Porter,K.,
            Rice,C.M., Rogosin,A., Ross,M.T., Sarafidou,T., Sehra,H.K.,
            Shownkeen,R., Skuce,C.D., Smith,M., Standring,L., Sycamore,N.,
            Tester,J., Thorpe,A., Torcasso,W., Tracey,A., Tromans,A., Tsolas,J.,
            Wall,M., Walsh,J., Wang,H., Weinstock,K., West,A.P., Willey,D.L.,
            Whitehead,S.L., Wilming,L., Wray,P.W., Young,L., Chen,Y.,
            Lovering,R.C., Moschonas,N.K., Siebert,R., Fechtel,K., Bentley,D.,
            Durbin,R., Hubbard,T., Doucette-Stamm,L., Beck,S., Smith,D.R. and
            Rogers,J.
  TITLE     The DNA sequence and comparative analysis of human chromosome 10
  JOURNAL   Nature 429 (6990), 375-381 (2004)
   PUBMED   15164054
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
REFERENCE   8  (residues 1 to 619)
  AUTHORS   Mural,R.J., Istrail,S., Sutton,G., Florea,L., Halpern,A.L.,
            Mobarry,C.M., Lippert,R., Walenz,B., Shatkay,H., Dew,I.,
            Miller,J.R., Flanigan,M.J., Edwards,N.J., Bolanos,R., Fasulo,D.,
            Halldorsson,B.V., Hannenhalli,S., Turner,R., Yooseph,S., Lu,F.,
            Nusskern,D.R., Shue,B.C., Zheng,X.H., Zhong,F., Delcher,A.L.,
            Huson,D.H., Kravitz,S.A., Mouchard,L., Reinert,K., Remington,K.A.,
            Clark,A.G., Waterman,M.S., Eichler,E.E., Adams,M.D.,
            Hunkapiller,M.W., Myers,E.W. and Venter,J.C.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-SEP-2005) to the EMBL/GenBank/DDBJ databases
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
REFERENCE   9  (residues 1 to 619)
  AUTHORS   Gerhard,D.S., Wagner,L., Feingold,E.A., Shenmen,C.M., Grouse,L.H.,
            Schuler,G., Klein,S.L., Old,S., Rasooly,R., Good,P., Guyer,M.,
            Peck,A.M., Derge,J.G., Lipman,D., Collins,F.S., Jang,W., Sherry,S.,
            Feolo,M., Misquitta,L., Lee,E., Rotmistrovsky,K., Greenhut,S.F.,
            Schaefer,C.F., Buetow,K., Bonner,T.I., Haussler,D., Kent,J.,
            Kiekhaus,M., Furey,T., Brent,M., Prange,C., Schreiber,K.,
            Shapiro,N., Bhat,N.K., Hopkins,R.F., Hsie,F., Driscoll,T.,
            Soares,M.B., Casavant,T.L., Scheetz,T.E., Brown-stein,M.J.,
            Usdin,T.B., Toshiyuki,S., Carninci,P., Piao,Y., Dudekula,D.B.,
            Ko,M.S., Kawakami,K., Suzuki,Y., Sugano,S., Gruber,C.E., Smith,M.R.,
            Simmons,B., Moore,T., Waterman,R., Johnson,S.L., Ruan,Y., Wei,C.L.,
            Mathavan,S., Gunaratne,P.H., Wu,J., Garcia,A.M., Hulyk,S.W., Fuh,E.,
            Yuan,Y., Sneed,A., Kowis,C., Hodgson,A., Muzny,D.M., McPherson,J.,
            Gibbs,R.A., Fahey,J., Helton,E., Ketteman,M., Madan,A.,
            Rodrigues,S., Sanchez,A., Whiting,M., Madari,A., Young,A.C.,
            Wetherby,K.D., Granite,S.J., Kwong,P.N., Brinkley,C.P.,
            Pearson,R.L., Bouffard,G.G., Blakesly,R.W., Green,E.D.,
            Dickson,M.C., Rodriguez,A.C., Grimwood,J., Schmutz,J., Myers,R.M.,
            Butterfield,Y.S., Griffith,M., Griffith,O.L., Krzywinski,M.I.,
            Liao,N., Morin,R., Palmquist,D., Petrescu,A.S., Skalska,U.,
            Smailus,D.E., Stott,J.M., Schnerch,A., Schein,J.E., Jones,S.J.,
            Holt,R.A., Baross,A., Marra,M.A., Clifton,S., Makowski,K.A.,
            Bosak,S. and Malek,J.
  CONSRTM   MGC Project Team
  TITLE     The status, quality, and expansion of the NIH full-length cDNA
            project: the Mammalian Gene Collection (MGC)
  JOURNAL   Genome Res 14 (10B), 2121-2127 (2004)
   PUBMED   15489334
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 10).; TISSUE=Uterus
            Erratum:[Genome Res. 2006 Jun;16(6):804. Morrin, Ryan [corrected to
            Morin, Ryan]]
REFERENCE   10  (residues 1 to 619)
  AUTHORS   Saeki,H., Tanaka,S. and Sugimachi,K.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-NOV-1999) to the EMBL/GenBank/DDBJ databases
  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 449-494.; TISSUE=Gastric carcinoma
REFERENCE   11  (residues 1 to 619)
  AUTHORS   He,T.C., Sparks,A.B., Rago,C., Hermeking,H., Zawel,L., da
            Costa,L.T., Morin,P.J., Vogelstein,B. and Kinzler,K.W.
  TITLE     Identification of c-MYC as a target of the APC pathway
  JOURNAL   Science 281 (5382), 1509-1512 (1998)
   PUBMED   9727977
  REMARK    FUNCTION.
REFERENCE   12  (residues 1 to 619)
  AUTHORS   Barker,N., Huls,G., Korinek,V. and Clevers,H.
  TITLE     Restricted high level expression of Tcf-4 protein in intestinal and
            mammary gland epithelium
  JOURNAL   Am J Pathol 154 (1), 29-35 (1999)
   PUBMED   9916915
  REMARK    TISSUE SPECIFICITY, INTERACTION WITH CTNNB1, AND SUBCELLULAR
            LOCATION.
REFERENCE   13  (residues 1 to 619)
  AUTHORS   Omer,C.A., Miller,P.J., Diehl,R.E. and Kral,A.M.
  TITLE     Identification of Tcf4 residues involved in high-affinity
            beta-catenin binding
  JOURNAL   Biochem Biophys Res Commun 256 (3), 584-590 (1999)
   PUBMED   10080941
  REMARK    INTERACTION WITH CTNNB1, AND MUTAGENESIS OF 10-ASP-ASP-11; ASP-16;
            GLU-17; 23-ASP-GLU-24 AND LEU-48.
REFERENCE   14  (residues 1 to 619)
  AUTHORS   Brantjes,H., Roose,J., van De Wetering,M. and Clevers,H.
  TITLE     All Tcf HMG box transcription factors interact with Groucho-related
            co-repressors
  JOURNAL   Nucleic Acids Res 29 (7), 1410-1419 (2001)
   PUBMED   11266540
  REMARK    INTERACTION WITH TLE1; TLE2; TLE3 AND TLE4.
REFERENCE   15  (residues 1 to 619)
  AUTHORS   van de Wetering,M., Sancho,E., Verweij,C., de Lau,W., Oving,I.,
            Hurlstone,A., van der Horn,K., Batlle,E., Coudreuse,D.,
            Haramis,A.P., Tjon-Pon-Fong,M., Moerer,P., van den Born,M.,
            Soete,G., Pals,S., Eilers,M., Medema,R. and Clevers,H.
  TITLE     The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype
            on colorectal cancer cells
  JOURNAL   Cell 111 (2), 241-250 (2002)
   PUBMED   12408868
  REMARK    FUNCTION.
REFERENCE   16  (residues 1 to 619)
  AUTHORS   Yamamoto,H., Ihara,M., Matsuura,Y. and Kikuchi,A.
  TITLE     Sumoylation is involved in beta-catenin-dependent activation of
            Tcf-4
  JOURNAL   EMBO J 22 (9), 2047-2059 (2003)
   PUBMED   12727872
  REMARK    SUMOYLATION AT LYS-320, INTERACTION WITH PIAS4, FUNCTION,
            SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-320 AND GLU-322.
REFERENCE   17  (residues 1 to 619)
  AUTHORS   Hecht,A. and Stemmler,M.P.
  TITLE     Identification of a promoter-specific transcriptional activation
            domain at the C terminus of the Wnt effector protein T-cell factor 4
  JOURNAL   J Biol Chem 278 (6), 3776-3785 (2003)
   PUBMED   12446687
  REMARK    INTERACTION WITH EP300.
REFERENCE   18  (residues 1 to 619)
  AUTHORS   Ishitani,T., Ninomiya-Tsuji,J. and Matsumoto,K.
  TITLE     Regulation of lymphoid enhancer factor 1/T-cell factor by
            mitogen-activated protein kinase-related Nemo-like kinase-dependent
            phosphorylation in Wnt/beta-catenin signaling
  JOURNAL   Mol Cell Biol 23 (4), 1379-1389 (2003)
   PUBMED   12556497
  REMARK    INTERACTION WITH NLK, PHOSPHORYLATION AT THR-201 AND/OR THR-212 BY
            NLK, AND MUTAGENESIS OF THR-201 AND THR-212.
REFERENCE   19  (residues 1 to 619)
  AUTHORS   Yamada,M., Ohnishi,J., Ohkawara,B., Iemura,S., Satoh,K.,
            Hyodo-Miura,J., Kawachi,K., Natsume,T. and Shibuya,H.
  TITLE     NARF, an nemo-like kinase (NLK)-associated ring finger protein
            regulates the ubiquitylation and degradation of T cell
            factor/lymphoid enhancer factor (TCF/LEF)
  JOURNAL   J Biol Chem 281 (30), 20749-20760 (2006)
   PUBMED   16714285
  REMARK    INTERACTION WITH NLK.
REFERENCE   20  (residues 1 to 619)
  AUTHORS   Grant,S.F., Thorleifsson,G., Reynisdottir,I., Benediktsson,R.,
            Manolescu,A., Sainz,J., Helgason,A., Stefansson,H., Emilsson,V.,
            Helgadottir,A., Styrkarsdottir,U., Magnusson,K.P., Walters,G.B.,
            Palsdottir,E., Jonsdottir,T., Gudmundsdottir,T., Gylfason,A.,
            Saemundsdottir,J., Wilensky,R.L., Reilly,M.P., Rader,D.J.,
            Bagger,Y., Christiansen,C., Gudnason,V., Sigurdsson,G.,
            Thorsteinsdottir,U., Gulcher,J.R., Kong,A. and Stefansson,K.
  TITLE     Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk
            of type 2 diabetes
  JOURNAL   Nat Genet 38 (3), 320-323 (2006)
   PUBMED   16415884
  REMARK    INVOLVEMENT IN NIDDM.
REFERENCE   21  (residues 1 to 619)
  AUTHORS   Horndasch,M., Lienkamp,S., Springer,E., Schmitt,A., Pavenstadt,H.,
            Walz,G. and Gloy,J.
  TITLE     The C/EBP homologous protein CHOP (GADD153) is an inhibitor of
            Wnt/TCF signals
  JOURNAL   Oncogene 25 (24), 3397-3407 (2006)
   PUBMED   16434966
  REMARK    INTERACTION WITH DDIT3.
REFERENCE   22  (residues 1 to 619)
  AUTHORS   Iwai,A., Hijikata,M., Hishiki,T., Isono,O., Chiba,T. and
            Shimotohno,K.
  TITLE     Coiled-coil domain containing 85B suppresses the beta-catenin
            activity in a p53-dependent manner
  JOURNAL   Oncogene 27 (11), 1520-1526 (2008)
   PUBMED   17873903
  REMARK    INTERACTION WITH CCDC85B.
REFERENCE   23  (residues 1 to 619)
  AUTHORS   Mahmoudi,T., Li,V.S., Ng,S.S., Taouatas,N., Vries,R.G., Mohammed,S.,
            Heck,A.J. and Clevers,H.
  TITLE     The kinase TNIK is an essential activator of Wnt target genes
  JOURNAL   EMBO J 28 (21), 3329-3340 (2009)
   PUBMED   19816403
  REMARK    INTERACTION WITH TNIK AND CTNNB1.
REFERENCE   24  (residues 1 to 619)
  AUTHORS   Hong,C.F., Chou,Y.T., Lin,Y.S. and Wu,C.W.
  TITLE     MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated
            epithelial-mesenchymal transdifferentiation
  JOURNAL   J Biol Chem 284 (29), 19613-19622 (2009)
   PUBMED   19443654
  REMARK    FUNCTION, AND INTERACTION WITH MAD2L2.
REFERENCE   25  (residues 1 to 619)
  AUTHORS   Lukas,J., Mazna,P., Valenta,T., Doubravska,L., Pospichalova,V.,
            Vojtechova,M., Fafilek,B., Ivanek,R., Plachy,J., Novak,J. and
            Korinek,V.
  TITLE     Dazap2 modulates transcription driven by the Wnt effector TCF-4
  JOURNAL   Nucleic Acids Res 37 (9), 3007-3020 (2009)
   PUBMED   19304756
  REMARK    INTERACTION WITH DAZAP2, AND SUBCELLULAR LOCATION.
REFERENCE   26  (residues 1 to 619)
  AUTHORS   Togi,S., Ikeda,O., Kamitani,S., Nakasuji,M., Sekine,Y., Muromoto,R.,
            Nanbo,A., Oritani,K., Kawai,T., Akira,S. and Matsuda,T.
  TITLE     Zipper-interacting protein kinase (ZIPK) modulates canonical
            Wnt/beta-catenin signaling through interaction with Nemo-like kinase
            and T-cell factor 4 (NLK/TCF4)
  JOURNAL   J Biol Chem 286 (21), 19170-19177 (2011)
   PUBMED   21454679
  REMARK    INTERACTION WITH NLK AND ZIPK/DAPK3.
REFERENCE   27  (residues 1 to 619)
  AUTHORS   Yu,Y., Wu,J., Wang,Y., Zhao,T., Ma,B., Liu,Y., Fang,W., Zhu,W.G. and
            Zhang,H.
  TITLE     Kindlin 2 forms a transcriptional complex with beta-catenin and TCF4
            to enhance Wnt signalling
  JOURNAL   EMBO Rep 13 (8), 750-758 (2012)
   PUBMED   22699938
  REMARK    FUNCTION, IDENTIFICATION IN A COMPLEX WITH FERMT2 AND CTNNB1, AND
            SUBCELLULAR LOCATION.
REFERENCE   28  (residues 1 to 619)
  AUTHORS   Satow,R., Shitashige,M., Jigami,T., Fukami,K., Honda,K.,
            Kitabayashi,I. and Yamada,T.
  TITLE     beta-catenin inhibits promyelocytic leukemia protein tumor
            suppressor function in colorectal cancer cells
  JOURNAL   Gastroenterology 142 (3), 572-581 (2012)
   PUBMED   22155184
  REMARK    INTERACTION WITH PML.
REFERENCE   29  (residues 1 to 619)
  AUTHORS   Wang,J.X., Zeng,Q., Chen,L., Du,J.C., Yan,X.L., Yuan,H.F., Zhai,C.,
            Zhou,J.N., Jia,Y.L., Yue,W. and Pei,X.T.
  TITLE     SPINDLIN1 promotes cancer cell proliferation through activation of
            WNT/TCF-4 signaling
  JOURNAL   Mol Cancer Res 10 (3), 326-335 (2012)
   PUBMED   22258766
  REMARK    INTERACTION WITH SPIN1.
REFERENCE   30  (residues 1 to 619)
  AUTHORS   Hanson,A.J., Wallace,H.A., Freeman,T.J., Beauchamp,R.D., Lee,L.A.
            and Lee,E.
  TITLE     XIAP monoubiquitylates Groucho/TLE to promote canonical Wnt
            signaling
  JOURNAL   Mol Cell 45 (5), 619-628 (2012)
   PUBMED   22304967
  REMARK    INTERACTION WITH XIAP/BIRC4 AND TLE3.
REFERENCE   31  (residues 1 to 619)
  AUTHORS   Su,X., Zhu,G., Ding,X., Lee,S.Y., Dou,Y., Zhu,B., Wu,W. and Li,H.
  TITLE     Molecular basis underlying histone H3 lysine-arginine methylation
            pattern readout by Spin/Ssty repeats of Spindlin1
  JOURNAL   Genes Dev 28 (6), 622-636 (2014)
   PUBMED   24589551
  REMARK    INTERACTION WITH SPIN1.
REFERENCE   32  (residues 1 to 619)
  AUTHORS   Bian,Y., Song,C., Cheng,K., Dong,M., Wang,F., Huang,J., Sun,D.,
            Wang,L., Ye,M. and Zou,H.
  TITLE     An enzyme assisted RP-RPLC approach for in-depth analysis of human
            liver phosphoproteome
  JOURNAL   J Proteomics 96, 253-262 (2014)
   PUBMED   24275569
  REMARK    IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].;
            TISSUE=Liver
REFERENCE   33  (residues 1 to 619)
  AUTHORS   Williams,A.L., Jacobs,S.B., Moreno-Macias,H., Huerta-Chagoya,A.,
            Churchhouse,C., Marquez-Luna,C., Garcia-Ortiz,H.,
            Gomez-Vazquez,M.J., Burtt,N.P., Aguilar-Salinas,C.A.,
            Gonzalez-Villalpando,C., Florez,J.C., Orozco,L., Haiman,C.A.,
            Tusie-Luna,T. and Altshuler,D.
  CONSRTM   SIGMA Type 2 Diabetes Consortium
  TITLE     Sequence variants in SLC16A11 are a common risk factor for type 2
            diabetes in Mexico
  JOURNAL   Nature 506 (7486), 97-101 (2014)
   PUBMED   24390345
  REMARK    INVOLVEMENT IN NIDDM.
REFERENCE   34  (residues 1 to 619)
  AUTHORS   Lu,Y., Xie,S., Zhang,W., Zhang,C., Gao,C., Sun,Q., Cai,Y., Xu,Z.,
            Xiao,M., Xu,Y., Huang,X., Wu,X., Liu,W., Wang,F., Kang,Y. and
            Zhou,T.
  TITLE     Twa1/Gid8 is a beta-catenin nuclear retention factor in Wnt
            signaling and colorectal tumorigenesis
  JOURNAL   Cell Res 27 (12), 1422-1440 (2017)
   PUBMED   28829046
  REMARK    INTERACTION WITH CTNNB1.
REFERENCE   35  (residues 1 to 619)
  AUTHORS   Bae,N., Gao,M., Li,X., Premkumar,T., Sbardella,G., Chen,J. and
            Bedford,M.T.
  TITLE     A transcriptional coregulator, SPIN.DOC, attenuates the coactivator
            activity of Spindlin1
  JOURNAL   J Biol Chem 292 (51), 20808-20817 (2017)
   PUBMED   29061846
  REMARK    INTERACTION WITH C11ORF84/SPINDOC AND SPIN1.
REFERENCE   36  (residues 1 to 619)
  AUTHORS   Hendriks,I.A., Lyon,D., Young,C., Jensen,L.J., Vertegaal,A.C. and
            Nielsen,M.L.
  TITLE     Site-specific mapping of the human SUMO proteome reveals
            co-modification with phosphorylation
  JOURNAL   Nat Struct Mol Biol 24 (3), 325-336 (2017)
   PUBMED   28112733
  REMARK    SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-22 AND LYS-539, AND
            IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
REFERENCE   37  (residues 1 to 619)
  AUTHORS   Han,F., Liu,W.B., Shi,X.Y., Yang,J.T., Zhang,X., Li,Z.M., Jiang,X.,
            Yin,L., Li,J.J., Huang,C.S., Cao,J. and Liu,J.Y.
  TITLE     SOX30 Inhibits Tumor Metastasis through Attenuating Wnt-Signaling
            via Transcriptional and Posttranslational Regulation of beta-Catenin
            in Lung Cancer
  JOURNAL   EBioMedicine 31, 253-266 (2018)
   PUBMED   29739711
  REMARK    INTERACTION WITH CTNNB1.
REFERENCE   38  (residues 1 to 619)
  AUTHORS   Graham,T.A., Ferkey,D.M., Mao,F., Kimelman,D. and Xu,W.
  TITLE     Tcf4 can specifically recognize beta-catenin using alternative
            conformations
  JOURNAL   Nat Struct Biol 8 (12), 1048-1052 (2001)
   PUBMED   11713475
  REMARK    X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 12-49 IN COMPLEX WITH THE
            ARMADILLO REPEAT REGION OF CTNNB1, AND MUTAGENESIS OF GLU-24;
            GLU-26; GLU-28 AND GLU-29.
REFERENCE   39  (residues 1 to 619)
  AUTHORS   Poy,F., Lepourcelet,M., Shivdasani,R.A. and Eck,M.J.
  TITLE     Structure of a human Tcf4-beta-catenin complex
  JOURNAL   Nat Struct Biol 8 (12), 1053-1057 (2001)
   PUBMED   11713476
  REMARK    X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 8-54 IN COMPLEX WITH THE
            ARMADILLO REPEAT REGION OF CTNNB1, AND MUTAGENESIS OF ILE-19 AND
            PHE-21.
REFERENCE   40  (residues 1 to 619)
  AUTHORS   Sampietro,J., Dahlberg,C.L., Cho,U.S., Hinds,T.R., Kimelman,D. and
            Xu,W.
  TITLE     Crystal structure of a beta-catenin/BCL9/Tcf4 complex
  JOURNAL   Mol Cell 24 (2), 293-300 (2006)
   PUBMED   17052462
  REMARK    X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 1-53 IN COMPLEX WITH BCL9
            AND CTNNB1, AND INTERACTION WITH CTNNB1.
REFERENCE   41  (residues 1 to 619)
  AUTHORS   Sjoblom,T., Jones,S., Wood,L.D., Parsons,D.W., Lin,J., Barber,T.D.,
            Mandelker,D., Leary,R.J., Ptak,J., Silliman,N., Szabo,S.,
            Buckhaults,P., Farrell,C., Meeh,P., Markowitz,S.D., Willis,J.,
            Dawson,D., Willson,J.K., Gazdar,A.F., Hartigan,J., Wu,L., Liu,C.,
            Parmigiani,G., Park,B.H., Bachman,K.E., Papadopoulos,N.,
            Vogelstein,B., Kinzler,K.W. and Velculescu,V.E.
  TITLE     The consensus coding sequences of human breast and colorectal
            cancers
  JOURNAL   Science 314 (5797), 268-274 (2006)
   PUBMED   16959974
  REMARK    VARIANT [LARGE SCALE ANALYSIS] CYS-465.
COMMENT     On Jul 17, 2007 this sequence version replaced gi:106288.
            [FUNCTION] Participates in the Wnt signaling pathway and modulates
            MYC expression by binding to its promoter in a sequence-specific
            manner. Acts as repressor in the absence of CTNNB1, and as
            activator in its presence. Activates transcription from promoters
            with several copies of the Tcf motif 5'-CCTTTGATC-3' in the
            presence of CTNNB1. TLE1, TLE2, TLE3 and TLE4 repress
            transactivation mediated by TCF7L2/TCF4 and CTNNB1. Expression of
            dominant-negative mutants results in cell-cycle arrest in G1.
            Necessary for the maintenance of the epithelial stem-cell
            compartment of the small intestine. {ECO:0000269|PubMed:12408868,
            ECO:0000269|PubMed:12727872, ECO:0000269|PubMed:19443654,
            ECO:0000269|PubMed:22699938, ECO:0000269|PubMed:9727977}.
            [SUBUNIT] Interacts with TGFB1I1 (By similarity). Interacts with
            CTNNB1 (via the armadillo repeat); forms stable transcription
            complex (PubMed:9065401, PubMed:9916915, PubMed:10080941,
            PubMed:19816403, PubMed:28829046, PubMed:29739711,
            PubMed:17052462). Interacts with EP300. Interacts with NLK.
            Interacts with CCDC85B (probably through the HMG box); prevents
            interaction with CTNNB1. Interacts with TNIK. Interacts with
            MAD2L2; prevents TCF7L2/TCF4 binding to promZIPK/DAPK3oters,
            negatively modulating its transcriptional activity. Interacts with
            ZIPK/DAPK3. Interacts with XIAP/BIRC4 and TLE3. Interacts with
            DDIT3/CHOP. The CTNNB1 and TCF7L2/TCF4 complex interacts with PML
            (isoform PML-4). Identified in a complex with CTNNB1 and FERMT2.
            Interacts with SPIN1 (PubMed:22258766, PubMed:24589551,
            PubMed:29061846). Interacts with C11orf84/SPINDOC in a
            SPIN1-dependent manner (PubMed:29061846). Interacts with DAZAP2;
            the interaction results in localization of DAZAP2 to the nucleus
            (PubMed:19304756). {ECO:0000250|UniProtKB:Q924A0,
            ECO:0000269|PubMed:10080941, ECO:0000269|PubMed:11266540,
            ECO:0000269|PubMed:12446687, ECO:0000269|PubMed:12556497,
            ECO:0000269|PubMed:12727872, ECO:0000269|PubMed:16434966,
            ECO:0000269|PubMed:16714285, ECO:0000269|PubMed:17052462,
            ECO:0000269|PubMed:17873903, ECO:0000269|PubMed:19304756,
            ECO:0000269|PubMed:19443654, ECO:0000269|PubMed:19816403,
            ECO:0000269|PubMed:21454679, ECO:0000269|PubMed:22155184,
            ECO:0000269|PubMed:22258766, ECO:0000269|PubMed:22304967,
            ECO:0000269|PubMed:22699938, ECO:0000269|PubMed:24589551,
            ECO:0000269|PubMed:28829046, ECO:0000269|PubMed:29061846,
            ECO:0000269|PubMed:29739711, ECO:0000269|PubMed:9065401,
            ECO:0000269|PubMed:9916915}.
            [INTERACTION] Q9NQB0; P35222: CTNNB1; NbExp=27; IntAct=EBI-924724,
            EBI-491549; Q9NQB0; Q9UER7: DAXX; NbExp=5; IntAct=EBI-924724,
            EBI-77321; Q9NQB0; Q14526: HIC1; NbExp=6; IntAct=EBI-924724,
            EBI-2507362; Q9NQB0; Q13761: RUNX3; NbExp=14; IntAct=EBI-924724,
            EBI-925990; Q9NQB0; Q9UKE5: TNIK; NbExp=3; IntAct=EBI-924724,
            EBI-1051794; Q9NQB0; Q93009: USP7; NbExp=2; IntAct=EBI-924724,
            EBI-302474; Q9NQB0; P12956: XRCC6; NbExp=10; IntAct=EBI-924724,
            EBI-353208; Q9NQB0-10; Q9NP55: BPIFA1; NbExp=3;
            IntAct=EBI-11746252, EBI-953896; Q9NQB0-10; Q5BKX5-3: C19orf54;
            NbExp=3; IntAct=EBI-11746252, EBI-11976299; Q9NQB0-10; Q9BYD5:
            CNFN; NbExp=3; IntAct=EBI-11746252, EBI-12819063; Q9NQB0-10;
            O43186: CRX; NbExp=3; IntAct=EBI-11746252, EBI-748171; Q9NQB0-10;
            A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-11746252, EBI-3867333;
            Q9NQB0-10; A1KXE4-2: FAM168B; NbExp=3; IntAct=EBI-11746252,
            EBI-12193763; Q9NQB0-10; Q08379: GOLGA2; NbExp=3;
            IntAct=EBI-11746252, EBI-618309; Q9NQB0-10; Q5TA45: INTS11;
            NbExp=3; IntAct=EBI-11746252, EBI-748258; Q9NQB0-10; P14923: JUP;
            NbExp=3; IntAct=EBI-11746252, EBI-702484; Q9NQB0-10; Q3LI72:
            KRTAP19-5; NbExp=3; IntAct=EBI-11746252, EBI-1048945; Q9NQB0-10;
            Q3SYF9: KRTAP19-7; NbExp=3; IntAct=EBI-11746252, EBI-10241353;
            Q9NQB0-10; Q3LI59: KRTAP21-2; NbExp=3; IntAct=EBI-11746252,
            EBI-18395721; Q9NQB0-10; Q3LI64: KRTAP6-1; NbExp=3;
            IntAct=EBI-11746252, EBI-12111050; Q9NQB0-10; Q3LI66: KRTAP6-2;
            NbExp=5; IntAct=EBI-11746252, EBI-11962084; Q9NQB0-10; Q8IUC3:
            KRTAP7-1; NbExp=3; IntAct=EBI-11746252, EBI-18394498; Q9NQB0-10;
            P35548: MSX2; NbExp=3; IntAct=EBI-11746252, EBI-6447480; Q9NQB0-10;
            Q9UF11-2: PLEKHB1; NbExp=3; IntAct=EBI-11746252, EBI-12832742;
            Q9NQB0-10; O43741: PRKAB2; NbExp=3; IntAct=EBI-11746252,
            EBI-1053424; Q9NQB0-10; P86480: PRR20D; NbExp=3;
            IntAct=EBI-11746252, EBI-12754095; Q9NQB0-10; Q53HV7-2: SMUG1;
            NbExp=3; IntAct=EBI-11746252, EBI-12275818; Q9NQB0-10; Q08117-2:
            TLE5; NbExp=3; IntAct=EBI-11746252, EBI-11741437; Q9NQB0-10;
            Q13077: TRAF1; NbExp=3; IntAct=EBI-11746252, EBI-359224; Q9NQB0-10;
            Q86WV8: TSC1; NbExp=3; IntAct=EBI-11746252, EBI-12806590;
            Q9NQB0-10; Q6NVU6: UFSP1; NbExp=3; IntAct=EBI-11746252,
            EBI-12068150.
            [SUBCELLULAR LOCATION] Nucleus, PML body
            {ECO:0000269|PubMed:12727872, ECO:0000269|PubMed:22699938,
            ECO:0000269|PubMed:9916915}. Nucleus {ECO:0000269|PubMed:19304756}.
            Note=Diffuse pattern. Colocalizes with SUMO1 and PIAS4 in a subset
            of PML (promyelocytic leukemia) nuclear bodies.
            [ALTERNATIVE PRODUCTS] Event=Alternative splicing; Named
            isoforms=17; Name=1; Synonyms=TCF-4M; IsoId=Q9NQB0-1;
            Sequence=Displayed; Name=2; IsoId=Q9NQB0-2; Sequence=VSP_006970,
            VSP_006972; Name=3; IsoId=Q9NQB0-3; Sequence=VSP_006966; Name=4;
            IsoId=Q9NQB0-4; Sequence=VSP_006964, VSP_006970, VSP_006972;
            Name=5; IsoId=Q9NQB0-5; Sequence=VSP_006964; Name=6;
            Synonyms=TCF-4I; IsoId=Q9NQB0-6; Sequence=VSP_006967; Name=7;
            IsoId=Q9NQB0-7; Sequence=VSP_006964, VSP_006966; Name=8;
            IsoId=Q9NQB0-8; Sequence=VSP_006962; Name=9; Synonyms=TCF-4G;
            IsoId=Q9NQB0-9; Sequence=VSP_006965, VSP_006969; Name=10;
            IsoId=Q9NQB0-10; Sequence=VSP_006962, VSP_006963, VSP_006968,
            VSP_006971; Name=11; IsoId=Q9NQB0-11; Sequence=VSP_006962,
            VSP_045821, VSP_006965, VSP_006969; Name=12; IsoId=Q9NQB0-12;
            Sequence=VSP_006962, VSP_045822; Name=13; Synonyms=TCF-4J;
            IsoId=Q9NQB0-13; Sequence=VSP_006962, VSP_006964, VSP_006966;
            Name=14; Synonyms=TCF-4B, short; IsoId=Q9NQB0-14;
            Sequence=VSP_006962, VSP_006965, VSP_006969; Name=15;
            Synonyms=TCF-4A; IsoId=Q9NQB0-15; Sequence=VSP_006962, VSP_053750,
            VSP_006965, VSP_006969; Name=16; Synonyms=TCF-4K; IsoId=Q9NQB0-16;
            Sequence=VSP_006962, VSP_053750, VSP_006964; Name=17;
            Synonyms=TCF-4X2; IsoId=Q9NQB0-17; Sequence=VSP_053748, VSP_053749.
            [TISSUE SPECIFICITY] Detected in epithelium from small intestine,
            with the highest expression at the top of the crypts and a gradient
            of expression from crypt to villus. Detected in colon epithelium
            and colon cancer, and in epithelium from mammary gland and
            carcinomas derived therefrom. {ECO:0000269|PubMed:9916915}.
            [DEVELOPMENTAL STAGE] Highly expressed in crypt regions and barely
            detectable in villi in epithelium from fetal small intestine at
            week 16. At week 22 expression in villi had increased strongly.
            [DOMAIN] The promoter-specific activation domain interacts with the
            transcriptional coactivator EP300.
            [PTM] In vitro, phosphorylated by TNIK.
            {ECO:0000269|PubMed:12556497}.
            [PTM] Phosphorylated at Thr-201 and/or Thr-212 by NLK.
            Phosphorylation by NLK at these sites inhibits DNA-binding by
            TCF7L2/TCF4, thereby preventing transcriptional activation of
            target genes of the canonical Wnt/beta-catenin signaling pathway.
            {ECO:0000269|PubMed:12556497}.
            [PTM] Polysumoylated. Sumoylation is enhanced by PIAS family
            members and desumoylation is enhanced by SENP2.
            Sumoylation/desumoylation regulates TCF7L2/TCF4 transcription
            activity in the Wnt/beta-catenin signaling pathway without altering
            interaction with CTNNB1 nor binding to DNA.
            {ECO:0000269|PubMed:12727872}.
            [DISEASE] Note=Constitutive activation and subsequent
            transactivation of target genes may lead to the maintenance of
            stem-cell characteristics (cycling and longevity) in cells that
            should normally undergo terminal differentiation and constitute the
            primary transforming event in colorectal cancer (CRC).
            [DISEASE] Diabetes mellitus, non-insulin-dependent (NIDDM)
            [MIM:125853]: A multifactorial disorder of glucose homeostasis
            caused by a lack of sensitivity to the body's own insulin. Affected
            individuals usually have an obese body habitus and manifestations
            of a metabolic syndrome characterized by diabetes, insulin
            resistance, hypertension and hypertriglyceridemia. The disease
            results in long-term complications that affect the eyes, kidneys,
            nerves, and blood vessels. {ECO:0000269|PubMed:16415884,
            ECO:0000269|PubMed:24390345}. Note=Disease susceptibility is
            associated with variants affecting the gene represented in this
            entry.
            [MISCELLANEOUS] [Isoform 12]: Low expression in pancreas and colon.
            {ECO:0000305}.
            [MISCELLANEOUS] [Isoform 13]: Common splicing form, lowest
            expression in skeletal muscle. {ECO:0000305}.
            [MISCELLANEOUS] [Isoform 14]: High transcriptional activity. Major
            isoform in liver. {ECO:0000305}.
            [SIMILARITY] Belongs to the TCF/LEF family. {ECO:0000305}.
FEATURES             Location/Qualifiers
     source          1..619
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
     gene            1..619
                     /gene="TCF7L2"
                     /gene_synonym="TCF4"
     Protein         1..619
                     /product="Transcription factor 7-like 2"
                     /note="HMG box transcription factor 4; T-cell-specific
                     transcription factor 4; T-cell factor 4; TCF-4; hTCF-4"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..619
                     /region_name="Mature chain"
                     /note="Transcription factor 7-like 2. /id=PRO_0000048623."
     Region          1..96
                     /region_name="Region of interest in the sequence"
                     /note="Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          1..53
                     /region_name="Region of interest in the sequence"
                     /note="CTNNB1-binding. /evidence=ECO:0000250."
     Region          1..6
                     /region_name="Splicing variant"
                     /note="MPQLNG -> MSSFLS (in isoform 17).
                     /evidence=ECO:0000303|PubMed:21256126. /id=VSP_053748."
     Region          7..290
                     /region_name="Splicing variant"
                     /note="Missing (in isoform 17).
                     /evidence=ECO:0000303|PubMed:21256126. /id=VSP_053749."
     Site            10..11
                     /site_type="mutagenized"
                     /note="DD->AA: Reduces CTNNB1 binding.
                     /evidence=ECO:0000269|PubMed:10080941."
     Region          16..46
                     /region_name="Compositionally biased region"
                     /note="Basic and acidic residues.
                     /evidence=ECO:0000256|SAM:MobiDB-lite."
     Site            16
                     /site_type="mutagenized"
                     /note="D->A: Abolishes CTNNB1 binding.
                     /evidence=ECO:0000269|PubMed:10080941."
     Region          17..259
                     /region_name="CTNNB1_binding"
                     /note="N-terminal CTNNB1 binding; pfam08347"
                     /db_xref="CDD:429937"
     Site            17
                     /site_type="mutagenized"
                     /note="E->A: Reduces CTNNB1 binding.
                     /evidence=ECO:0000269|PubMed:10080941."
     Site            19
                     /site_type="mutagenized"
                     /note="I->A: Reduces transcription activation.
                     /evidence=ECO:0000269|PubMed:11713476."
     Site            21
                     /site_type="mutagenized"
                     /note="F->A: Reduces transcription activation.
                     /evidence=ECO:0000269|PubMed:11713476."
     Region          22..31
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:1JDH."
     Bond            22
                     /bond_type="xlink"
                     /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
                     G-Cter in SUMO2). /evidence=ECO:0007744|PubMed:28112733."
     Site            23..24
                     /site_type="mutagenized"
                     /note="DE->AA: Reduces CTNNB1 binding.
                     /evidence=ECO:0000269|PubMed:10080941."
     Site            24
                     /site_type="mutagenized"
                     /note="E->A: Reduces CTNNB1 binding, and abolishes CTNNB1
                     binding; when associated with A-26; A-28 and A-29.
                     /evidence=ECO:0000269|PubMed:11713475."
     Site            26
                     /site_type="mutagenized"
                     /note="E->A: Abolishes CTNNB1 binding; when associated with
                     A-24; A-28 and A-29.
                     /evidence=ECO:0000269|PubMed:11713475."
     Site            28
                     /site_type="mutagenized"
                     /note="E->A: Abolishes CTNNB1 binding; when associated with
                     A-24; A-26 and A-29.
                     /evidence=ECO:0000269|PubMed:11713475."
     Site            29
                     /site_type="mutagenized"
                     /note="E->A: Reduces CTNNB1 binding, and abolishes CTNNB1
                     binding; when associated with A-24; A-26 and A-28.
                     /evidence=ECO:0000269|PubMed:11713475."
     Region          38..48
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:1JDH."
     Region          47..63
                     /region_name="Compositionally biased region"
                     /note="Polar residues.
                     /evidence=ECO:0000256|SAM:MobiDB-lite."
     Site            48
                     /site_type="mutagenized"
                     /note="L->A: Abolishes CTNNB1 binding.
                     /evidence=ECO:0000269|PubMed:10080941."
     Region          64..91
                     /region_name="Compositionally biased region"
                     /note="Basic and acidic residues.
                     /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          118..121
                     /region_name="Conflict"
                     /note="NGSL -> KRSV (in Ref. 2; CAB97212/CAB97213).
                     /evidence=ECO:0000305."
     Region          128..150
                     /region_name="Splicing variant"
                     /note="Missing (in isoform 8, isoform 10, isoform 11,
                     isoform 12, isoform 13, isoform 14, isoform 15 and isoform
                     16). /evidence=ECO:0000303|PubMed:14702039,
                     ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:19602480,
                     ECO:0000303|PubMed:21256126, ECO:0000303|PubMed:9065401.
                     /id=VSP_006962."
     Region          167
                     /region_name="Conflict"
                     /note="Q -> R (in Ref. 4; ADK35180).
                     /evidence=ECO:0000305."
     Region          184
                     /region_name="Splicing variant"
                     /note="V ->
                     VSPLPCCTQGHDCQHFYPPSDFTVSTQVFRDMKRSHSLQKVGEPWCIE (in
                     isoform 11). /evidence=ECO:0000305. /id=VSP_045821."
     Region          201..395
                     /region_name="Region of interest in the sequence"
                     /note="Mediates interaction with MAD2L2.
                     /evidence=ECO:0000269|PubMed:19443654."
     Site            201
                     /site_type="phosphorylation"
                     /note="Phosphothreonine; by NLK.
                     /evidence=ECO:0000305|PubMed:12556497."
     Site            201
                     /site_type="mutagenized"
                     /note="T->V: Reduced phosphorylation by NLK and enhanced
                     DNA-binding; when associated with V-212.
                     /evidence=ECO:0000269|PubMed:12556497."
     Site            212
                     /site_type="phosphorylation"
                     /note="Phosphothreonine; by NLK.
                     /evidence=ECO:0000305|PubMed:12556497."
     Site            212
                     /site_type="mutagenized"
                     /note="T->V: Reduced phosphorylation by NLK and enhanced
                     DNA-binding; when associated with V-201.
                     /evidence=ECO:0000269|PubMed:12556497."
     Region          226
                     /region_name="Conflict"
                     /note="P -> L (in Ref. 4; ADK35180).
                     /evidence=ECO:0000305."
     Region          260..263
                     /region_name="Splicing variant"
                     /note="Missing (in isoform 10).
                     /evidence=ECO:0000303|PubMed:15489334. /id=VSP_006963."
     Region          290
                     /region_name="Splicing variant"
                     /note="M -> MSSFLS (in isoform 15 and isoform 16).
                     /evidence=ECO:0000303|PubMed:21256126. /id=VSP_053750."
     Region          290
                     /region_name="Conflict"
                     /note="M -> V (in Ref. 1; CAA72166).
                     /evidence=ECO:0000305."
     Region          318..350
                     /region_name="Region of interest in the sequence"
                     /note="Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          318..332
                     /region_name="Compositionally biased region"
                     /note="Polar residues.
                     /evidence=ECO:0000256|SAM:MobiDB-lite."
     Bond            320
                     /bond_type="xlink"
                     /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
                     G-Cter in SUMO). /evidence=ECO:0000269|PubMed:12727872."
     Site            320
                     /site_type="mutagenized"
                     /note="K->R: Loss of sumoylation. No effect on localization
                     to nuclear bodies. /evidence=ECO:0000269|PubMed:12727872."
     Site            322
                     /site_type="mutagenized"
                     /note="E->A: Loss of sumoylation.
                     /evidence=ECO:0000269|PubMed:12727872."
     Region          331
                     /region_name="Conflict"
                     /note="L -> H (in Ref. 3; ACI28527).
                     /evidence=ECO:0000305."
     Region          333..350
                     /region_name="Compositionally biased region"
                     /note="Basic and acidic residues.
                     /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          346
                     /region_name="Variant"
                     /note="K -> N (in dbSNP:rs2757884).
                     /evidence=ECO:0000269|PubMed:10919662. /id=VAR_047126."
     Region          349..433
                     /region_name="HMG-box_TCF7-like"
                     /note="high mobility group (HMG)-box found in the
                     transcription factor 7 (TCF-7)-like family; cd21996"
                     /db_xref="CDD:438812"
     Site            order(349,351..358,361..362,365,375..378,381..382,385,400,
                     404,407,418..433)
                     /site_type="DNA binding"
                     /note="DNA binding site [nucleotide binding]"
                     /db_xref="CDD:438812"
     Site            350..418
                     /site_type="DNA binding"
                     /note="HMG box.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00267."
     Region          420..441
                     /region_name="Region of interest in the sequence"
                     /note="Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          425..430
                     /region_name="Short sequence motif of biological interest"
                     /note="Nuclear localization signal. /evidence=ECO:0000255."
     Region          440..465
                     /region_name="Splicing variant"
                     /note="EHSECFLNPCLSLPPITDLSAPKKCR ->
                     GEKKSAFATYKVKAAASAHPLQMEAY (in isoform 9, isoform 11,
                     isoform 14 and isoform 15).
                     /evidence=ECO:0000303|PubMed:14702039,
                     ECO:0000303|PubMed:19602480, ECO:0000303|PubMed:21256126,
                     ECO:0000303|PubMed:9065401, ECO:0000303|Ref.5.
                     /id=VSP_006965."
     Region          440..456
                     /region_name="Splicing variant"
                     /note="Missing (in isoform 4, isoform 5, isoform 7, isoform
                     13 and isoform 16). /evidence=ECO:0000303|PubMed:19602480,
                     ECO:0000303|PubMed:21256126. /id=VSP_006964."
     Region          457..619
                     /region_name="Splicing variant"
                     /note="DLSAPKKCRARFGLDQQNNWCGPCRRKKKCVRYIQGEGSCLSPPSSDGSLL
                     DSPPPSPNLLGSPPRDAKSQTEQTQPLSLSLKPDPLAHLSMMPPPPALLLAEATHKAS
                     ALCPNGALDLPPAALQPAAPSSSIAQPSTSSLHSHSSLAGTQPQPLSLVTKSLE ->
                     GEKKSAFATYKVKAAASAHPLQMEAY (in isoform 6).
                     /evidence=ECO:0000303|PubMed:21256126. /id=VSP_006967."
     Region          457..482
                     /region_name="Splicing variant"
                     /note="DLSAPKKCRARFGLDQQNNWCGPCRR ->
                     GEKKSAFATYKVKAAASAHPLQMEAY (in isoform 10).
                     /evidence=ECO:0000303|PubMed:15489334. /id=VSP_006968."
     Region          457..478
                     /region_name="Splicing variant"
                     /note="DLSAPKKCRARFGLDQQNNWCG -> DANTPKKCRALFGLDRQTLWCK (in
                     isoform 3, isoform 7 and isoform 13).
                     /evidence=ECO:0000303|PubMed:19602480,
                     ECO:0000303|PubMed:21256126. /id=VSP_006966."
     Region          459..505
                     /region_name="Region of interest in the sequence"
                     /note="Promoter-specific activation domain."
     Region          465
                     /region_name="Variant"
                     /note="R -> C (in a colorectal cancer sample; somatic
                     mutation). /evidence=ECO:0000269|PubMed:16959974.
                     /id=VAR_035939."
     Region          466..619
                     /region_name="Splicing variant"
                     /note="Missing (in isoform 9, isoform 11, isoform 14 and
                     isoform 15). /evidence=ECO:0000303|PubMed:14702039,
                     ECO:0000303|PubMed:19602480, ECO:0000303|PubMed:21256126,
                     ECO:0000303|PubMed:9065401, ECO:0000303|Ref.5.
                     /id=VSP_006969."
     Region          481..619
                     /region_name="Splicing variant"
                     /note="RRKKKCVRYIQGEGSCLSPPSSDGSLLDSPPPSPNLLGSPPRDAKSQTEQT
                     QPLSLSLKPDPLAHLSMMPPPPALLLAEATHKASALCPNGALDLPPAALQPAAPSSSI
                     AQPSTSSLHSHSSLAGTQPQPLSLVTKSLE -> SL (in isoform 12).
                     /evidence=ECO:0000303|PubMed:19602480. /id=VSP_045822."
     Region          482..494
                     /region_name="Splicing variant"
                     /note="RKKKCVRYIQGEG -> CKYSKEVSGTVRA (in isoform 2 and
                     isoform 4). /evidence=ECO:0000305. /id=VSP_006970."
     Region          483..619
                     /region_name="Splicing variant"
                     /note="Missing (in isoform 10).
                     /evidence=ECO:0000303|PubMed:15489334. /id=VSP_006971."
     Region          495..619
                     /region_name="Splicing variant"
                     /note="Missing (in isoform 2 and isoform 4).
                     /evidence=ECO:0000305. /id=VSP_006972."
     Region          496..547
                     /region_name="Region of interest in the sequence"
                     /note="Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          520..537
                     /region_name="Compositionally biased region"
                     /note="Polar residues.
                     /evidence=ECO:0000256|SAM:MobiDB-lite."
     Bond            539
                     /bond_type="xlink"
                     /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
                     G-Cter in SUMO2). /evidence=ECO:0007744|PubMed:28112733."
     Region          574..619
                     /region_name="Region of interest in the sequence"
                     /note="Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          584..619
                     /region_name="Compositionally biased region"
                     /note="Polar residues.
                     /evidence=ECO:0000256|SAM:MobiDB-lite."
     Region          596
                     /region_name="Conflict"
                     /note="S -> W (in Ref. 1; CAA72166).
                     /evidence=ECO:0000305."
ORIGIN
        1 mpqlnggggd dlgandelis fkdegeqeek ssenssaerd ladvksslvn esetnqnsss
       61 dseaerrppp rsesfrdksr esleeaakrq dgglfkgppy pgypfimipd ltspylpngs
      121 lsptartlhf qsgsthysay ktiehqiavq ylqmkwplld vqagslqsrq alkdarspsp
      181 ahivsnkvpv vqhphhvhpl tplitysneh ftpgnppphl padvdpktgi prpphppdis
      241 pyyplspgtv gqiphplgwl vpqqgqpvyp ittggfrhpy ptaltvnasm srfpphmvpp
      301 hhtlhttgip hpaivtptvk qessqsdvgs lhsskhqdsk keeekkkphi kkplnafmly
      361 mkemrakvva ectlkesaai nqilgrrwha lsreeqakyy elarkerqlh mqlypgwsar
      421 dnygkkkkrk rdkqpgetne hsecflnpcl slppitdlsa pkkcrarfgl dqqnnwcgpc
      481 rrkkkcvryi qgegsclspp ssdgslldsp ppspnllgsp prdaksqteq tqplslslkp
      541 dplahlsmmp pppalllaea thkasalcpn galdlppaal qpaapsssia qpstsslhsh
      601 sslagtqpqp lslvtksle
//
